Annotation Detail for PPP1R7
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of PPP1R7 mRNA | increases expression | 20406850
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PPP1R7 mRNA | affects expression | 21346803
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of PPP1R7 mRNA | decreases expression | 15336504
|
| C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of PPP1R7 mRNA | increases expression | 17616710
|
| C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of PPP1R7 mRNA | affects expression | 17440010
|
| C025643 |
vinclozolin |
vinclozolin affects the expression of PPP1R7 mRNA | affects expression | 19015723
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.93 | 19015723 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.79 | 16705839 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.00 | 6135515 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.78 | 14966744 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.50 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
2.04 | 18551238 21346803 |
| MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.84 | 15547733 15150132 15264214 15547721 16510608 16704527 15878914 16805852 15623463 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.47 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.91 | 16417039 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.36 | 17440010 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.26 | 16467254 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.28 | 16705839 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.27 | 16417039 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.25 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.74 | 2876784 2876786 6135515 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.40 | 7678174 18551238 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.78 | 16049721 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.44 | 18220299 18042343 19015723 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.47 | 18220299 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.47 | 18629315 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.76 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.83 | 8532709 |
| MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.33 | 17575124 12958204 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.40 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.86 | 10091137 |
Related Pathway Information